Rafivirumab

Rafivirumab is a monoclonal antibody for the prophylaxis of rabies.[1]

Rafivirumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	rabies virus glycoprotein
Clinical data
ATC code	none
Identifiers
CAS Number	944548-37-2^N
ChemSpider	none
UNII	F6G4126BPE
Chemical and physical data
Formula	C₆₄₆₂H₉₉₅₄N₁₇₁₈O₂₀₃₆S₄₆
Molar mass	145761.46 g·mol⁻¹
^NY (what is this?) (verify)

References

International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.

Monoclonal antibodies for infectious disease and toxins

Human	Efungumab^†

Human	Ansuvimab Atoltivimab (+maftivimab/odesivimab) Bamlanivimab^† Casirivimab^† (+imdevimab)^† Diridavumab^§ Exbivirumab^§ Foravirumab^§ Imdevimab^† Libivirumab^§ Maftivimab Odesivimab Rafivirumab^§ Regavirumab^§ Sevirumab^† Suptavumab Tuvirumab^§
Chimeric	Cosfroviximab Larcaviximab Porgaviximab
Humanized	Felvizumab^§ Lenvervimab^† Motavizumab^† Palivizumab Suvizumab^§

Human	Nebacumab Panobacumab^§ Raxibacumab
Mouse	Edobacomab^§
Chimeric	Pagibaximab^†
Humanized	Tefibazumab^†

Human	Actoxumab^§ Bezlotoxumab Suvratoxumab
Chimeric	Obiltoxaximab
Humanized	Urtoxazumab^§

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.